In our research, we validated miR-1287-5p-targeted PAK2, and overexpression of PAK2 attenuated the suppressive of miR-1287-5p in the malignant phenotypes of NSCLC cells. The gene discussed is PAK2; the disease is non-small cell lung carcinoma.